Andrew A. Hindman - May 20, 2021 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
SVP, Chief Financial Officer
Signature
Brett A. Grimaud as Attorney-in-Fact
Stock symbol
TBPH
Transactions as of
May 20, 2021
Transactions value $
-$16,768
Form type
4
Date filed
5/24/2021, 06:10 PM
Next filing
Aug 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Tax liability -$16.8K -942 -0.51% $17.80 185K May 20, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,082 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 14, 2021.